Reason for Not Prescribing *Anticoagulation* Therapy at Discharge (v2020A)

Specifications Manual for Joint Commission National Quality Measures (v2020A)

Posted: August 1, 2019

Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)

Print this page

Home » Reason for Not Prescribing Anticoagulation Therapy at Discharge

Release Notes:
Data Element
Version 2020A

Name:

Reason for Not Prescribing Anticoagulation Therapy at Discharge

Collected For:

STK-3

Definition:

Reason for not prescribing anticoagulation therapy at hospital discharge.

Other reason documented by physician/APN/PA or pharmacist

The administration of anticoagulation therapy, unless there are contraindications, is an established effective strategy in preventing recurrent stroke in high stroke risk-atrial fibrillation patients with TIA or prior stroke.

Question:

Is there documentation by a physician/advanced practice nurse/physician assistant (physician/APN/PA) or pharmacist in the medical record of a reason for not prescribing anticoagulation therapy at hospital discharge?

Format:

Length:	1
Type:	Alphanumeric
Occurs:	1

Allowable Values:

Y (Yes) There is documentation of a reason for not prescribing anticoagulation therapy at hospital discharge.

N (No) There is no documentation of a reason for not prescribing anticoagulation therapy at hospital discharge, OR unable to determine from the medical record documentation.

Notes for Abstraction:

Reasons for not prescribing anticoagulation therapy at hospital discharge must be documented by a physician/APN/PA or pharmacist with one exception: Patient/family refusal of any form of anticoagulation therapy (e.g., “Coumadin refused,” “Patient refusing anticoagulation therapy”) may be documented by a nurse.
If reasons are not mentioned in the context of anticoagulation therapy, do not make inferences (e.g., do not assume that anticoagulation therapy was not prescribed because of a bleeding disorder unless documentation explicitly states so).
- Reasons must be explicitly documented (e.g., “Active GI bleed – anticoagulation therapy contraindicated,” “No warfarin” [no reason given]).
- Consider the term "blood thinners" synonymous with anticoagulant therapy. Physician/APN/PA or pharmacist documentation, e.g., "no blood thinners", select "Yes".
- Documentation of "do not continue" or “do not convert” a home anticoagulant medication to an inpatient medication, or an inpatient anticoagulant medication to a discharge medication, does not count as a reason for not prescribing anticoagulation therapy at discharge. Do not infer that an anticoagulant medication was not prescribed or discontinued without explicit documentation of a reason for not prescribing an anticoagulant medication at discharge.
  Example:
  Patient on Coumadin 2.5 mg while an inpatient. During discharge medication reconciliation, physician checks “do not convert” box next to Coumadin, select “No.”
- Deferral of anticoagulation therapy from one physician/APN/PA or pharmacist to another does NOT count as a reason for not prescribing anticoagulation therapy at discharge unless the problem underlying the deferral is also noted.
  Examples:
  - “Consulting neurologist to evaluate pt. for warfarin therapy.” - select “No.”
  - “Rule out GI bleed. Start Coumadin if OK with gastroenterology” - select "Yes.”
- If there is documentation of a plan to initiate/restart anticoagulation therapy, and the reason/problem underlying the delay in starting/restarting anticoagulation therapy is also noted, this constitutes a “clearly implied” reason for not prescribing anticoagulation therapy at discharge.
  Acceptable examples (select “Yes”):
  - “Stool Occult Blood positive. May start Coumadin as outpatient.”
  - “Start warfarin if hematuria subsides.”
  Unacceptable examples (select “No”):
  - “Consider starting Coumadin in a.m.”
  - “May add warfarin when pt. can tolerate”
- Reasons do NOT need to be documented at discharge or otherwise linked to the discharge timeframe: Documentation of reasons anytime during the hospital stay are acceptable (e.g., mid-hospitalization note stating “no warfarin due to rectal bleeding” - select “Yes,” even if documentation indicates that the rectal bleeding has resolved by the time of discharge and warfarin was restarted).
An allergy or adverse reaction to one type of anticoagulant would NOT be a reason for not administering all anticoagulants. Another medication can be ordered.
When conflicting information is documented in a medical record, select “Yes.”
When the current record includes documentation of a pre-arrival reason for no antithrombotic therapy, the following counts regardless of whether this documentation is included in a pre-arrival record made part of the current record or whether it is noted by hospital staff during the current hospital stay:
Example:
"Hx GI bleeding with warfarin" documented in a transferring record.

Suggested Data Sources:

ONLY PHYSICIAN/APN/PA OR PHARMACIST DOCUMENTATION OF A REASON FOR NOT PRESCRIBING ANTICOAGULATION THERAPY AT HOSPITAL DISCHARGE:

Consultation notes
Emergency department record
History and physical
Progress notes
Physician orders
Discharge summary
After Visit Summary (AVS)
Medication administration record (MAR)

Excluded Data Sources: Any documentation dated/timed after discharge, except discharge summary.

Additional Notes:

Guidelines for Abstraction:

Inclusion	Exclusion
None Refer to Appendix C, Table 8.3 for a comprehensive list of Anticoagulant Medications.	Anticoagulant medication allergy described using one of the negative modifiers or qualifiers listed in Appendix H, Table 2.6, Qualifiers and Modifiers Table.

Specifications Manual for Joint Commission National Quality Measures (v2020A)
Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.